Published in Clin Exp Vaccine Res on July 29, 2015
Clinical Trial of the PfSPZ Vaccine | NCT01001650
Phase I Trial of DAR-901 | NCT02063555
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | NCT00116441
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med (2010) 29.75
A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J (2011) 8.65
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature (1967) 6.08
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol (2006) 5.72
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis (2002) 5.43
Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37
The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA (1994) 5.29
Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol (1998) 5.05
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science (2013) 4.60
Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev (2010) 4.49
Protection against a malaria challenge by sporozoite inoculation. N Engl J Med (2009) 4.03
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet (2011) 2.98
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol (2015) 2.98
Salmonella, the host and disease: a brief review. Immunol Cell Biol (2006) 2.95
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin (2010) 2.36
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol (2003) 2.32
Vaccines and vaccination. N Engl J Med (2001) 2.23
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun (2006) 2.20
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun (2001) 2.19
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis (Edinb) (2013) 2.10
Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev (2012) 2.03
At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol (2013) 1.90
A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J (2012) 1.87
Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med (2013) 1.84
Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. AIDS (2010) 1.76
Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol (2004) 1.74
Historical review of pertussis and the classical vaccine. J Infect Dis (1996) 1.65
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Vaccine (2014) 1.46
Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. Lancet Respir Med (2014) 1.42
Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol (2005) 1.37
Targeted vaccine selection in influenza vaccination. Dtsch Arztebl Int (2013) 1.36
Sipuleucel-T: a vaccine for metastatic, asymptomatic, androgen-independent prostate cancer. Ann Pharmacother (2007) 1.24
Vaccination with irradiated Listeria induces protective T cell immunity. Immunity (2006) 1.23
Review of accidents caused by incomplete inactivation of viruses. Dev Biol Stand (1993) 1.20
Review of an inactivated vaccine against hantaviruses. Intervirology (2002) 1.14
Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent. J Infect Dis (2007) 1.13
Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine (2005) 1.11
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis. Ann Oncol (2011) 1.09
Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control (2005) 1.06
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae. J Infect Dis (2014) 1.06
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis. Vaccine (2010) 1.03
Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov (2014) 1.03
Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes. Int J Radiat Oncol Biol Phys (2014) 1.03
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies. PLoS One (2014) 1.03
Immunogenicity of irradiated Salmonella typhimurium cells and endotoxin. J Bacteriol (1968) 1.02
Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol Cell Biol (1988) 0.99
The long journey: a brief review of the eradication of rinderpest. Rev Sci Tech (2012) 0.99
Inactivation of DNA by beta-propiolactone. Biologicals (1995) 0.97
Inactivation of a non-enveloped RNA virus by artificial ribonucleases: honey bees and acute bee paralysis virus as a new experimental model for in vivo antiviral activity assessment. Antiviral Res (2011) 0.96
Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-Peptide complex from Deinococcus. Cell Host Microbe (2012) 0.96
Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51. Clin Diagn Lab Immunol (2005) 0.96
Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection. PLoS One (2013) 0.95
Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques. Clin Vaccine Immunol (2013) 0.95
PCV13 impact evaluations: the obvious and the unpredicted. Pediatr Infect Dis J (2013) 0.95
THE IMMUNIZATION OF FOWLS AGAINST MOSQUITO-BORNE PLASMODIUM GALLINACEUM BY INJECTIONS OF SERUM AND OF INACTIVATED HOMOLOGOUS SPOROZOITES. J Exp Med (1942) 0.94
Cross-reactive cytotoxic T cells to alphavirus infection. Scand J Immunol (1979) 0.94
Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England. Epidemiol Infect (2012) 0.93
Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol (1996) 0.92
Respiration of gamma irradiated Brucella abortus and Mycobacterium tuberculosis. Proc Soc Exp Biol Med (1962) 0.91
Gamma radiation induced mutagenesis in Aspergillus niger to enhance its microbial fermentation activity for industrial enzyme production. Mol Biol Rep (2010) 0.91
Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology (1994) 0.91
Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis. J Infect Dis (2014) 0.91
Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates. Clin Vaccine Immunol (2006) 0.90
Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013. Appl Health Econ Health Policy (2014) 0.90
Vaccines in cancer: GVAX, a GM-CSF gene vaccine. Expert Rev Vaccines (2005) 0.90
Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses. J Biol Chem (2011) 0.89
Tuberculosis vaccines--state of the art, and novel approaches to vaccine development. Int J Infect Dis (2015) 0.88
Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice. Infect Immun (2009) 0.88
The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review. Curr Opin Infect Dis (2013) 0.87
Who was concerned about radiation, food safety, and natural disasters after the great East Japan earthquake and Fukushima catastrophe? A nationwide cross-sectional survey in 2012. PLoS One (2014) 0.87
Anthrax vaccine: a review. Immunol Allergy Clin North Am (2003) 0.87
Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicity. J Virol Methods (2014) 0.86
The gamma-irradiated influenza vaccine and the prospect of producing safe vaccines in general. Immunol Cell Biol (2009) 0.85
A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected thai subjects with CD4-cell counts of >300. Clin Diagn Lab Immunol (2000) 0.85
Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge. Vaccine (2010) 0.85
Betting on a malaria vaccine. N Engl J Med (2005) 0.85
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy. Blood Cancer J (2013) 0.85
Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium. J Ind Microbiol Biotechnol (2008) 0.85
Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97. Trans R Soc Trop Med Hyg (2000) 0.85
[Historical review of smallpox, the eradication of smallpox and the attenuated smallpox MVA vaccine]. Berl Munch Tierarztl Wochenschr (1999) 0.84
Tuberculosis vaccine development at a divide. Curr Opin Pulm Med (2014) 0.84
Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine. Vaccine (2012) 0.84
Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer. Drug Saf (2001) 0.84
Live attenuated influenza vaccine--a review. J Prev Med Hyg (2011) 0.83
Proposed mechanisms of action for prostate cancer vaccines. Nat Rev Urol (2013) 0.82
A review of the smallpox vaccine adverse events active surveillance system. Clin Infect Dis (2008) 0.82
Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer. P T (2011) 0.82
Inactivation of Influenza A virus, Adenovirus, and Cytomegalovirus with PAXgene tissue fixative and formalin. Biopreserv Biobank (2013) 0.81
Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection. J Infect Dis (2012) 0.81
IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. J Infect Dis (1987) 0.81
Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin. J Urol (2013) 0.81
Inactivated- or killed-virus HIV/AIDS vaccines. Curr Drug Targets Infect Disord (2005) 0.81